Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417]
- RabMAb
- Recombinant
- What is this?
5
(3 Reviews)
|
(10 Publications)
Rabbit Recombinant Monoclonal ACAT2/Acetyl-CoA acetyltransferase antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 10 publications.
View Alternative Names
ACTL, ACAT2, Acetyl-CoA transferase-like protein, Cytosolic acetoacetyl-CoA thiolase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417] (AB131215)
Immunohistochemical analysis of paraffin embedded Human liver tissue labelling ACAT2/Acetyl-CoA acetyltransferase with ab131215 antibody at 1/100 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417] (AB131215)
All lanes:
Western blot - Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417] (ab131215) at 1/1000 dilution
Lane 1:
HepG2 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
Jurkat cell lysate at 10 µg
Lane 4:
K562 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 41 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417] (AB131215)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-ACAT2/Acetyl-CoA acetyltransferase antibody [EPR8417] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This enzyme facilitates the synthesis of cholesterol and ketone bodies essential processes for cellular energy balance. ACAT2 works as an independent enzyme rather than as a component of a multi-enzyme complex unlike some other acetyltransferases. By managing acetyl-CoA levels it supports energy homeostasis and lipogenesis providing substrates for downstream processes that are critical for sustaining cellular function and response to energy demands.
Pathways
The acetyl-transfer reactions catalyzed by ACAT2 are integral to the cholesterol biosynthesis and ketogenesis pathways. These pathways are important for energy balance and lipid modification. Within these pathways ACAT2 acts in close relation with HMG-CoA synthase an important player in cholesterol biosynthesis. The enzyme’s actions provide acetoacetyl-CoA which is a substrate for the production of HMG-CoA highlighting its role in maintaining metabolic flux.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Diagnostic pathology 19:7 PubMed38178203
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 62:754-770 PubMed36920044
2023
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 12: PubMed36978970
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of dairy science 105:7773-7786 PubMed35940922
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:927118 PubMed35912092
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bioenergetics and biomembranes 53:415-428 PubMed34036483
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 14:70 PubMed33902674
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 24:711-727 PubMed33996254
2021
Applications
Unspecified application
Species
Unspecified reactive species
Yonsei medical journal 61:780-788 PubMed32882762
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:3477-3488 PubMed32425549
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com